Rock Solid

Täglich 2 Kapseln unzerkaut mit ausreichend Wasser einnehmen.

Wir empfehlen die Einnahme vom Rock Solid nicht auf nüchternen Magen, sondern im Vorfeld eine Kleinigkeit gegessen zu haben.

• Charge: C0148262
• Charge: C0143812
• Charge: C0143809
• Charge: C0143805
• Charge: C0143802

1. B. Fitzgerald, G. R. McLatchie, ”Degenerative joint disease in weight-lifters. Fact or fiction?” Br J Sports Med. 1980 Jul; 14(2-3): 97–101.
2. Lopresti AL, Maes M, Maker GL, Hood SD, Drummond PD., ”Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study.”, J Affect Disord. 2014;167:368-75. doi: 10.1016/j.jad.2014.06.001. Epub 2014 Jun 11.
3. Sanmukhani J, Satodia V, Trivedi J, Patel T, Tiwari D, Panchal B, Goel A, Tripathi CB., ”Efficacy and safety of curcumin in major depressive disorder: a randomized controlled trial.”, Phytother Res. 2014 Apr;28(4):579-85. doi: 10.1002/ptr.5025. Epub 2013 Jul 6.
4. Belcaro G, Cesarone MR, Dugall M, Pellegrini L, Ledda A, Grossi MG, Togni S, Appendino G., ”Efficacy and safety of Meriva®, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients.”, Altern Med Rev. 2010 Dec;15(4):337-44.
5. Belcaro G, Cesarone MR, Dugall M, Pellegrini L, Ledda A, Grossi MG, Togni S, Appendino G., ”Product-evaluation registry of Meriva®, a curcumin-phosphatidylcholine complex, for the complementary management of osteoarthritis.”, Panminerva Med. 2010 Jun;52(2 Suppl 1):55-62.
6. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB., ”Bioavailability of curcumin: problems and promises.”, Mol Pharm. 2007 Nov-Dec;4(6):807-18. Epub 2007 Nov 14.
7. Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS., ”Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers.”, Planta Med. 1998 May;64(4):353-6.
8. Sahdeo Prasad, PhD, Amit K. Tyagi, PhD, and Bharat B. Aggarwal, PhD, ”Recent Developments in Delivery, Bioavailability, Absorption and Metabolism of Curcumin: the Golden Pigment from Golden Spice.”, Cancer Res Treat. 2014 Jan; 46(1): 2–18.
9. Gimsa U, Sieper J, Braun J, Mitchison NA. ”Type II collagen serology: a guide to clinical responsiveness to oral tolerance?” Rheumatol Int. 1997;16(6):237-240. doi:10.1007/bf01375655.
10. P. Benito-Ruiz, M.M. Camacho-Zambrano, J.N. Carrillo-Arcentales, M.A. Mestanza-Peralta, C.A. Vallejo-Flores, S.V. Vargas-López, R.A. Villacís-Tamayo & L.A. Zurita-Gavilanes, ”A randomized controlled trial on the efficacy and safety of a food ingredient, collagen hydrolysate, for improving joint comfort”, International Journal of Food Sciences and Nutrition Volume 60, 2009.
11. Trentham DE, Dynesius-Trentham RA, Orav EJ, Combitchi D, Lorenzo C, Sewell KL, Hafler DA, Weiner HL., ”Effects of oral administration of type II collagen on rheumatoid arthritis.”, Science. 1993 Sep 24;261(5129):1727-30.
12. Crowley DC, Lau FC, Sharma P, Evans M, Guthrie N, Bagchi M, Bagchi D, Dey DK, Raychaudhuri SP., ”Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee: a clinical trial.”, Int J Med Sci. 2009 Oct 9;6(6):312-21.
13. Sengupta K, Alluri KV, Satish AR, Mishra S, Golakoti T, Sarma KV, Dey D, Raychaudhuri SP., ”A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee.”, Arthritis Res Ther. 2008;10(4):R85. doi: 10.1186/ar2461. Epub 2008 Jul 30.
14. Vishal AA, Mishra A, Raychaudhuri SP., ”A double blind, randomized, placebo controlled clinical study evaluates the early efficacy of aflapin in subjects with osteoarthritis of knee.”, Int J Med Sci. 2011;8(7):615-22. Epub 2011 Oct 12.
15. Gupta PK, Samarakoon SM, Chandola HM, Ravishankar B., ”Clinical evaluation of Boswellia serrata (Shallaki) resin in the management of Sandhivata (osteoarthritis).”, Ayu. 2011 Oct;32(4):478-82. doi: 10.4103/0974-8520.96119.
16. Agarwal KA, Tripathi CD, Agarwal BB, Saluja S., ”Efficacy of turmeric (curcumin) in pain and postoperative fatigue after laparoscopic cholecystectomy: a double-blind, randomized placebo-controlled study.”, Surg Endosc. 2011 Dec;25(12):3805-10. doi: 10.1007/s00464-011-1793-z. Epub 2011 Jun 14.
17. Di Pierro F, Rapacioli G, Di Maio EA, Appendino G, Franceschi F, Togni S., ”Comparative evaluation of the pain-relieving properties of a lecithinized formulation of curcumin (Meriva(®)), nimesulide, and acetaminophen.”, J Pain Res. 2013;6:201-5. doi: 10.2147/JPR.S42184. Epub 2013 Mar 8.
18. Belcaro G, Cesarone MR, Dugall M, Pellegrini L, Ledda A, Grossi MG, Togni S, Appendino G., ”Product-evaluation registry of Meriva®, a curcumin-phosphatidylcholine complex, for the complementary management of osteoarthritis.”, Panminerva Med. 2010 Jun;52(2 Suppl 1):55-62.
19. Deutsche Gesellschaft für Rheumatologie, Kommission Versorgung (2008). Memorandum Rheumatologische Versorgung von akut und chronisch Rheumakranken in Deutschland. www.dgrh.de
20. Musculoskeletal Health in Europe. Report v5.0. http://www.eumusc.net/workpackages_wp4.cfm ;last access: 28.07.2015
21. Musculoskeletal Health in Europe. Report v5.0 http://www.eumusc.net/workpackages_wp4.cfm; last access: 28.07.2015
22. Zink A, Albrecht K. Wie häufig sind muskuloskelettale Erkrankungen in Deutschland? Z Rheumatol 2016;75:346-353
23. In: Watts RA, Conaghan PG, Denton C, Foster H, Isaacs J, Müller-Ladner U (Hrsg.): Oxford Symmons D. Epidemiology and the rheumatic diseases. Textbook of Rheumatology (4 ed.), Chapter 27. Oxford (Oxford University Press) 2013
24. Burmester G-R, Pratt AG, Scherer HU, van Laar JM. Rheumatoid arthritis: Pathogenesis and clinical features. In: Bijlsma JWJ (ed.) EULAR textbook on rheumatic diseases. London (BMJ Group) 2012, S. 206-231
25. Belcaro G, Cesarone MR, Dugall M, Pellegrini L, Ledda A, Grossi MG, Togni S, Appendino G., ”Efficacy and safety of Meriva®, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients.”, Altern Med Rev. 2010 Dec;15(4):337-44.
26. Chainani-Wu N, Madden E, Lozada-Nur F, Silverman S Jr. ”High-dose curcuminoids are efficacious in the reduction in symptoms and signs of oral lichen planus.” J Am Acad Dermatol. 2012 May;66(5):752-60. doi: 10.1016/j.jaad.2011.04.022. Epub 2011 Sep 9.
27. Khajehdehi P, Pakfetrat M, Javidnia K, Azad F, Malekmakan L, Nasab MH, Dehghanzadeh G., ”Oral supplementation of turmeric attenuates proteinuria, transforming growth factor-β and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: a randomized, double-blind and placebo-controlled study.”, Scand J Urol Nephrol. 2011 Nov;45(5):365-70. doi: 10.3109/00365599.2011.585622. Epub 2011 May 31.
28. DiSilvestro RA, Joseph E, Zhao S, Bomser J., ”Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people.”, Nutr J. 2012 Sep 26;11:79. doi: 10.1186/1475-2891-11-79.
29. Kalpravidh RW, Siritanaratkul N, Insain P, Charoensakdi R, Panichkul N, Hatairaktham S, Srichairatanakool S, Phisalaphong C, Rachmilewitz E, Fucharoen S., ”Improvement in oxidative stress and antioxidant parameters in beta-thalassemia/Hb E patients treated with curcuminoids.”, Clin Biochem. 2010 Mar;43(4-5):424-9. doi: 10.1016/j.clinbiochem.2009.10.057. Epub 2009 Nov 10.
30. Durgaprasad S, Pai CG, Vasanthkumar, Alvres JF, Namitha S., ”A pilot study of the antioxidant effect of curcumin in tropical pancreatitis.”, Indian J Med Res. 2005 Oct;122(4):315-8.
31. Panahi Y, Rahimnia AR, Sharafi M, Alishiri G, Saburi A, Sahebkar A., ”Curcuminoid treatment for knee osteoarthritis: a randomized double-blind placebo-controlled trial.”, Phytother Res. 2014 Nov;28(11):1625-31. doi: 10.1002/ptr.5174. Epub 2014 May 22.
32. Belcaro G, Cesarone MR, Dugall M, Pellegrini L, Ledda A, Grossi MG, Togni S, Appendino G., ”Efficacy and safety of Meriva®, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients.”, Altern Med Rev. 2010 Dec;15(4):337-44.
33. Sengupta K, Krishnaraju AV, Vishal AA, Mishra A, Trimurtulu G, Sarma KV, Raychaudhuri SK, Raychaudhuri SP., ”Comparative efficacy and tolerability of 5-Loxin and AflapinAgainst osteoarthritis of the knee: a double blind, randomized, placebo controlled clinical study.”, Int J Med Sci. 2010 Nov 1;7(6):366-77.

Spüre den Unterschied ohne Risiko.
30 Tage Geld-zurück-Garantie.

Wir sind bis zur letzten Muskelfaser von der Wissenschaft und der Qualität unserer Produkte überzeugt – und darum erhältst Du bei uns eine risikofreie 30 Tage Geld-zurück-Garantie.

Überzeuge Dich somit selbst von der Qualität unserer Produkte.